Lupin's Strategic Leap: Tackling Obesity and Diabetes in India

Lupin's Strategic Leap: Tackling Obesity and Diabetes in India

Lupin's Strategic Leap: Tackling Obesity and Diabetes in India Drug maker Lupin announced on Monday a new exclusive licensing, supply, and distribution agreement with Chinese company Gan & Lee Pharmaceuticals. The partnership aims to introduce a cutting-edge medication for obesity and diabetes treatment in India.This strategic move advances Lupin's diabetes portfolio and bolsters its presence in the burgeoning obesity market. The medication in f…

Lupin Signs Licensing, Supply And Distribution Deal With Chinese Firm For Obesity Drug

Drug maker Lupin on Monday said it has entered into an exclusive licensing, supply and distribution pact with China-based Gan & Lee Pharmaceuticals for a novel medication to treat obesity and diabetes. The Mumbai-based drug maker said the agreement strengthens the company's diabetes portfolio and accelerates its presence in the obesity segment.

Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist